{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:06:53Z","timestamp":1793995613464,"version":"4.8.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2025YFC3409400"],"award-info":[{"award-number":["2025YFC3409400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92156025"],"award-info":[{"award-number":["92156025"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32372580"],"award-info":[{"award-number":["32372580"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004517","name":"Tianjin University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004517","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejmech.2025.118430","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T16:05:10Z","timestamp":1764605110000},"page":"118430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["ATTEC-mediated degradation of BCR-ABL in chronic myeloid leukemia cells"],"prefix":"10.1016","volume":"303","author":[{"given":"Zhiyan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-An","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runqi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boao","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunrong","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2595-9106","authenticated-orcid":false,"given":"Zhiguang","family":"Yuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118430_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5306\/wjco.v12.i2.69","article-title":"Chronic myeloid leukemia-from the Philadelphia chromosome to specific target drugs: a literature review","volume":"12","author":"Sampaio","year":"2021","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118430_bib2","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1001\/jama.2025.0220","article-title":"Chronic myeloid leukemia: a review","volume":"333","author":"Jabbour","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2025.118430_bib3","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1038\/s41375-020-01082-4","article-title":"Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets","volume":"35","author":"Adnan-Awad","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2025.118430_bib4","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/ajh.27443","article-title":"Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring","volume":"99","author":"Jabbour","year":"2024","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ejmech.2025.118430_bib5","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ccell.2020.03.006","article-title":"Response and resistance to BCR-ABL1-targeted therapies","volume":"37","author":"Braun","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2025.118430_bib6","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1007\/s00018-019-03397-7","article-title":"Elucidation of protein interactions necessary for the maintenance of the BCR-ABL signaling complex","volume":"77","author":"Gregor","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2025.118430_bib7","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.3390\/ijms26146591","article-title":"The coiled coil and C2 domains modulate BCR localization and BCR-ABL1 compartmentalization, transforming activity and TKI responsiveness","volume":"26","author":"Massimino","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118430_bib8","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nchembio.954","article-title":"Domain organization differences explain BCR-ABL's preference for CrkL over CrkII","volume":"8","author":"Jankowski","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118430_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cytogfr.2025.05.001","article-title":"BCR-ABL: the molecular mastermind behind chronic myeloid leukemia","volume":"83","author":"Shammas","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ejmech.2025.118430_bib10","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.bpj.2022.05.030","article-title":"The structural basis of BCR-ABL recruitment of GRB2 in chronic myelogenous leukemia","volume":"121","author":"Liu","year":"2022","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejmech.2025.118430_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41571-023-00736-3","article-title":"Protein degraders enter the clinic - a new approach to cancer therapy","volume":"20","author":"Chirnomas","year":"2023","journal-title":"Nat. Rev. Clin. Oncology"},{"key":"10.1016\/j.ejmech.2025.118430_bib12","doi-asserted-by":"crossref","first-page":"13194","DOI":"10.1039\/D1CC04661F","article-title":"Developing potent LC3-targeting AUTAC tools for protein degradation with selective autophagy","volume":"57","author":"Pei","year":"2021","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2025.118430_bib13","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/s41422-021-00532-7","article-title":"Degradation of lipid droplets by chimeric autophagy-tethering compounds","volume":"31","author":"Fu","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2025.118430_bib14","doi-asserted-by":"crossref","first-page":"8832","DOI":"10.1039\/D2CS00624C","article-title":"Emerging degrader technologies engaging lysosomal pathways","volume":"51","author":"Ding","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2025.118430_bib15","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/lifemedi\/lnac043","article-title":"Manipulating autophagic degradation in human diseases: from mechanisms to interventions","volume":"1","author":"Zhang","year":"2022","journal-title":"Life Med"},{"key":"10.1016\/j.ejmech.2025.118430_bib16","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/anie.201507634","article-title":"Modular PROTAC design for the degradation of oncogenic BCR-ABL","volume":"55","author":"Lai","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.118430_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128653","article-title":"Targeting epigenetic modulators using PROTAC degraders: current status and future perspective","volume":"63","author":"Webb","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118430_bib18","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tips.2020.04.005","article-title":"Emerging new concepts of degrader technologies","volume":"41","author":"Ding","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2025.118430_bib19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-019-1722-1","article-title":"Allele-selective lowering of mutant HTT protein by HTT\u2013LC3 linker compounds","volume":"575","author":"Li","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118430_bib20","doi-asserted-by":"crossref","first-page":"11192","DOI":"10.1039\/D3SC03600F","article-title":"Targeting mitochondrial degradation by chimeric autophagy-tethering compounds","volume":"14","author":"Liu","year":"2023","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2025.118430_bib21","doi-asserted-by":"crossref","first-page":"12877","DOI":"10.1021\/acs.jmedchem.3c00828","article-title":"Degradation of cyclin-dependent kinase 9\/cyclin T1 by optimized microtubule-associated protein 1 light chain 3 beta-recruiting coumarin analogs","volume":"28","author":"Zeng","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118430_bib22","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1158\/0008-5472.CAN-05-4187","article-title":"The structure of dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants","volume":"66","author":"Tokarski","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118430_bib23","first-page":"273","article-title":"Current strategies for the design of PROTAC linkers: a critical review, explor. Target","volume":"1","author":"Troup","year":"2020","journal-title":"Antitumor Ther."},{"key":"10.1016\/j.ejmech.2025.118430_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116520","article-title":"Application and challenges of nitrogen heterocycles in PROTAC linker","volume":"273","author":"Li","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118430_bib25","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ardp.201500109","article-title":"Synthesis, biological, and computational evaluation of novel 1,3,5-substituted indolin-2-one derivatives as inhibitors of src tyrosine kinase","volume":"348","author":"Kilic-Kurt","year":"2015","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2025.118430_bib26","article-title":"A kinase-independent BCR-ABL function mediating an Hsp70-Bim protein-protein interaction in chronic myeloid leukemia","volume":"310","author":"Zhang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2025.118430_bib27","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.1093\/emboj\/cdf562","article-title":"The src family kinase hck couples BCR\/ABL to STAT5 activation in myeloid leukemia cells","volume":"21","author":"Klejman","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2025.118430_bib28","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1038\/leu.2015.196","article-title":"\u03b2-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia","volume":"29","author":"Eiring","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2025.118430_bib29","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ctrv.2010.02.015","article-title":"Dasatinib: a potent SRC inhibitor in clinical development for the treatment of solid tumors","volume":"36","author":"Araujo","year":"2010","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.ejmech.2025.118430_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4056398","article-title":"The activity of novel BCR-ABL small-molecule degraders containing pyrimidine rings and their role in overcoming drug resistance","volume":"2022","author":"Zhang","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.ejmech.2025.118430_bib31","doi-asserted-by":"crossref","first-page":"8567","DOI":"10.1021\/acs.jmedchem.0c00967","article-title":"Global PROTAC toolbox for degrading BCR\u2013ABL overcomes drug-resistant mutants and adverse effects","volume":"63","author":"Yang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118430_bib32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/chin.200242072","article-title":"Interesting product formation during o\u2010alkylation and subsequent rearrangement of two building blocks of dibromotyrosine based natural products","volume":"33","author":"Mallavadhani","year":"2002","journal-title":"ChemInform"},{"key":"10.1016\/j.ejmech.2025.118430_bib33","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1021\/acsmedchemlett.9b00025","article-title":"Identification of new small-molecule inducers of estrogen-related receptor \u03b1 (ERR\u03b1) degradation","volume":"10","author":"Peng","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118430_bib34","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1002\/chem.201003285","article-title":"Fluorometric sensing of biogenic amines with aggregation\u2010induced emission\u2010active tetraphenylethenes","volume":"17","author":"Nakamura","year":"2011","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2025.118430_bib35","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.1021\/acs.jmedchem.1c02013","article-title":"Discovery of pentacyclic triterpenoid PROTACs as a class of effective hemagglutinin protein degraders","volume":"65","author":"Li","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118430_bib36","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/cmdc.202000466","article-title":"Targeting G protein\u2010coupled receptors with magnetic carbon nanotubes: the case of the A3 adenosine receptor","volume":"15","author":"Pineux","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118430_bib37","article-title":"Unraveling dynamic helicity inversion and chirality transfer through the synthesis of discrete azobenzene oligomers by an iterative exponential growth strategy","volume":"63","author":"Wang","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.118430_bib38","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2025.118430_bib39","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1042\/BJ20121907","article-title":"Structural basis for phosphorylation-triggered autophagic clearance of salmonella","volume":"454","author":"Rogov","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2025.118430_bib40","doi-asserted-by":"crossref","first-page":"26105","DOI":"10.1002\/anie.202109464","article-title":"Inhibition of autophagy by a small molecule through covalent modification of the LC3 protein","volume":"60","author":"Fan","year":"2021","journal-title":"Angew. Chem. Int. Edit."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342501195X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342501195X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:44:46Z","timestamp":1781325886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342501195X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":40,"alternative-id":["S022352342501195X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118430","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ATTEC-mediated degradation of BCR-ABL in chronic myeloid leukemia cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118430","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118430"}}